Testing effectiveness (Phase 2)Looking for participantsNCT07014917
What this trial is testing
Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL
Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaCLL Variant
Zulfa Omer 62